Levopront Nursing Consideration

Updated
Can you update this thread? Please share your knowledge, experience, or questions about this subject. Post a Reply if you can help. Thank you!

it is an antitussive drug, it can cause dizziness, somnolence, nausea, vomiting, heartburn, diarrhea, abdominal discomfort, faintness, palpitaions, clouding of consciousness, numbness, exhaustion, it is indicated to dry cough

More Discussions:

nursing consideration of buscopan

nursing consideration of buscopan ## Butylscopolamine, also known as scopolamine butylbromide and hyoscine butylbromide,...

6 REPLIES
nursing consideration

as a nurse, what are the interventions that you will do to patients experiencing the side effects of nubain? ## I really...

4 REPLIES
NURSING CONSIDERATIONS OF HIDRASEC

NURSING CONSIDERATIONS OF HIDRASEC ## need to know bout this ## yes ## I'm sorry, we do get a lot of these types of ...

4 REPLIES
nursing consideration of anti cholinergec agents

nursing consideration of anti cholinergec agents ## Nursing Consideration Of Anti Cholinergic Agents ## Here's the l...

2 REPLIES
nursing consideration of ferrous fumarate

nakaron brand name ## WHAT IS THE NURSING INTERVENTION FOR FOLIC ACID?...

1 REPLY
Nursing Consideration Of Hidrasec

thank u for this gooles researh who help me a lot to solve my problem to easy find the answer. ## i need this details...

1 REPLY
nursing consideration of ranitidine

how does it effect to a liver disease or any other diagnosis. ## Ranitidine is a histamine H2 receptor agonist that help...

1 REPLY
nursing consideration of iterax

nursing consideration of iterax for patient whose in tosilitis ## Iterax contains the active ingredient Hydroxyzine, it ...

1 REPLY
nursing consideration for giving antiseizure medicine

nursing consideration when giving anti-seizure medicine ## Many of them can be specific to the specific class of medicat...

1 REPLY
nursing consideration of dulcolax

nursing consideration of dulcolax ## it can help everyone who had a problem in drugs...

1 REPLY